Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Oncogene|February 3, 2004
The ATR-p53 pathway is suppressed in noncycling normal and malignant lymphocytesGillian G Jones, Philip M Reaper, Andrew R Pettitt, et al.Oncogene|August 17, 2005
Basic fibroblast growth factor suppresses p53 activation in the neoplastic cells of a proportion of patients with chronic lymphocytic leukaemiaVadim V Romanov, Christine H James, Paul D Sherrington, et al.Blood|August 1, 2002
Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemiaKe Lin, Paul D Sherrington, Michael Dennis, et al.Cancer Research|June 4, 2009
A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 geneGillian G Johnson, Paul D Sherrington, Anthony Carter, et al.Cancer Research|August 17, 2005
B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemiaDavid J Allsup, Aura S Kamiguti, Ke Lin, et al.Haematologica|November 11, 2003
V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemiaVeronique M Duke, Domenica Gandini, Paul D Sherrington, et al.British Journal of Haematology|November 1, 2012
The gene expression signature associated with TP53 mutation/deletion in chronic lymphocytic leukaemia is dominated by the under-expression of TP53 and other genes on chromosome 17pKe Lin, Brian Lane, Anthony Carter, et al.Pageof 1